Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127810) titled 'Clinical Evaluation of Dexmedetomidine in Improving Long-Term Prognosis of Children with ADHD by Regulating Circadian Rhythm Disorders' on July 8.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Wuhan Childrens Hospital
Condition:
ADHD with sleep-wake rhythm disorder
Intervention:
Intervention group:On the basis of the original rehabilitation treatment and daytime oral medication treatment, for three consecutive days, at 22:00, dexmedetomidine at a dose of 1 µ g/kg was sprayed nasal. The total volume of the drug was divided into two equal parts, and small amounts were sprayed ...